FDA Ignores Safety Committee’s Guidance, Authorizes Pfizer Booster for 65 and Older, Plus ‘High Risk’ Groups • Children's Health Defense

The FDA amended the EUA for Pfizer-BioNTech COVID vaccine.

FDA Ignores Safety Committee’s Guidance, Authorizes Pfizer Booster for 65 and Older, Plus ‘High Risk’ Groups

Critics slammed the decision, calling it “unjustified and unethical” and a “consolation prize” for Pfizer, which wanted approval for everyone in the general population, over age 16.